ArticleJournal of clinical medicine2024

Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia.

Alessandro Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.